Clinical Trials in Miami

Showing 2401-2420 of 9,821 trials

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

NCT05886894

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

Refractive Errors

Alcon Research351 participantsStarted Aug 2023

San Diego, California, United States • Jacksonville, Florida, United States • Miami, Florida, United States +5 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS).

Carcinoma, Renal Cell

Merck Sharp & Dohme LLC1,800 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • La Jolla, California, United States +282 more locations

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Find Trials by Condition in Miami

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Topical ENS-002 for Atopic Dermatitis in Adults

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Expanded Access of Sotorasib

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours